Lipoprotein and HDL Function Core
脂蛋白和HDL功能核心
基本信息
- 批准号:10544050
- 负责人:
- 金额:$ 23.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:Anti-Inflammatory AgentsAntiatherogenicAntiinflammatory EffectApolipoprotein A-IIApoproteinsAtherosclerosisBiological AssayCholesterolChronic Kidney FailureCost AnalysisDevelopmentDiseaseFamilial HypercholesterolemiaFunctional disorderGoalsHealth Services AccessibilityHigh Density LipoproteinsImpairmentIndividualInflammationInflammatoryLaboratoriesLipoproteinsMacrophageMediationMethodologyMethodsPost-Translational Protein ProcessingPreparationProceduresProcessProtein AnalysisResearchResearch PersonnelResearch Project GrantsRheumatoid ArthritisScienceServicesStandardizationTraining and Educationatheroprotectiveatherosclerosis riskcostexperimental studyhuman diseasein vitro Assayinstrumentationmethod developmentoxidationreverse cholesterol transport
项目摘要
Summary
Anti-atherogenic functions of HDL are likely due to its mediation of reverse cholesterol transport
and to its anti-oxidative and anti-inflammatory effects. Mounting evidence supports the concept
that HDL may become dysfunctional and that this contributes to the development of
atherosclerosis. The goal of our research is to define the mechanisms for HDL dysfunction in
diseases associated with significantly increased risk of atherosclerotic cardiovascular disease,
including familial hypercholesterolemia, chronic kidney disease and rheumatoid arthritis. A major
hypothesis of our proposal is that excessive inflammatory and oxidative burden impair HDL
atheroprotective functions, including cholesterol efflux capacity and anti-inflammatory and anti-
oxidative effects. Core B will be an integral part of the PPG by providing both analytical services
for analysis and isolation of lipoproteins and in vitro assays of HDL function in macrophages. The
goal of Specific Aim 1 is to provide isolation and analysis of lipoproteins, HDL subfractions, and
apoproteins. The Lipoprotein and HDL Function Core (Core B) will assist investigators by isolating
lipoproteins and apoproteins, including apoAI and apoAII, for functional studies and analyses of
protein modifications. The goal of Specific Aim 2 is to provide assays for HDL functions, including
the promotion of cholesterol efflux and efferocytosis in macrophages and the control of
inflammation and oxidation. Core B provides a number of services to investigators that require
unique instrumentation and methodologies and demand rigorous standardization procedures. It
would be costly, inefficient, and cumbersome to establish these procedures in individual
investigator laboratories. The consolidation of these services into the Core B laboratory provides
investigators with efficient, high quality, low-cost analyses. Another objective of Core B is to
provide education and training to investigators, fellows, and research technicians on the science
and methods of lipoprotein preparation and studies of HDL function.
总结
HDL的抗动脉粥样硬化功能可能是由于其介导的胆固醇逆向转运
以及其抗氧化和抗炎作用。越来越多的证据支持了
HDL可能变得功能失调,这有助于发展
动脉粥样硬化我们研究的目的是确定HDL功能障碍的机制,
与动脉粥样硬化性心血管疾病风险显著增加相关的疾病,
包括家族性高胆固醇血症、慢性肾病和类风湿性关节炎。一个主要
我们提出假设是过度的炎症和氧化负荷损害HDL
动脉粥样硬化保护功能,包括胆固醇流出能力和抗炎和抗
氧化作用。核心B将通过提供两种分析服务,
用于脂蛋白的分析和分离以及巨噬细胞中HDL功能的体外测定。的
具体目标1的目标是提供脂蛋白、HDL亚组分和
脱辅基蛋白脂蛋白和HDL功能核心(核心B)将通过分离
脂蛋白和载脂蛋白,包括apoAI和apoAII,用于功能研究和分析,
蛋白质修饰Specific Aim 2的目标是提供HDL功能的测定,包括
促进巨噬细胞中胆固醇流出和巨噬细胞增多,
炎症和氧化。核心B为研究者提供了许多服务,
独特的仪器和方法,并要求严格的标准化程序。它
将是昂贵的,低效的,繁琐的,建立这些程序在个人
实验室调查员将这些服务整合到核心B实验室,
研究人员提供高效、高质量、低成本的分析。核心B的另一个目标是
为研究人员、研究员和研究技术人员提供科学方面的教育和培训
以及脂蛋白的制备方法和HDL功能的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MACRAE F LINTON其他文献
MACRAE F LINTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MACRAE F LINTON', 18)}}的其他基金
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs
巨噬细胞 SR-BI 调节自噬、血管生成素和 tRNA 衍生的小 RNA
- 批准号:
9029105 - 财政年份:2016
- 资助金额:
$ 23.76万 - 项目类别:
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs
巨噬细胞 SR-BI 调节自噬、血管生成素和 tRNA 衍生的小 RNA
- 批准号:
9195133 - 财政年份:2016
- 资助金额:
$ 23.76万 - 项目类别:
Dicarbonyl Scavengers to Improve HDL Function and Reduce Atherosclerosis in FH
二羰基清除剂可改善 FH 中的 HDL 功能并减少动脉粥样硬化
- 批准号:
10327715 - 财政年份:2014
- 资助金额:
$ 23.76万 - 项目类别:
Dicarbonyl Scavengers to Improve HDL Function and Reduce Atherosclerosis in FH
二羰基清除剂可改善 FH 中的 HDL 功能并减少动脉粥样硬化
- 批准号:
10089340 - 财政年份:2014
- 资助金额:
$ 23.76万 - 项目类别:
相似海外基金
Antiatherogenic effects of neutrophil alpha defensins
中性粒细胞α防御素的抗动脉粥样硬化作用
- 批准号:
8360808 - 财政年份:2012
- 资助金额:
$ 23.76万 - 项目类别:
Antiatherogenic effects of neutrophil alpha defensins
中性粒细胞α防御素的抗动脉粥样硬化作用
- 批准号:
8505376 - 财政年份:2012
- 资助金额:
$ 23.76万 - 项目类别:
Antiatherogenic effects of high density lipoprotein and sphingosine 1-phosphate
高密度脂蛋白和1-磷酸鞘氨醇的抗动脉粥样硬化作用
- 批准号:
18590973 - 财政年份:2006
- 资助金额:
$ 23.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of the mechanisms for antiatherogenic effect of bone marrow AT2 receptor by using gene-targeted mice
基因靶向小鼠分析骨髓AT2受体抗动脉粥样硬化作用机制
- 批准号:
17590760 - 财政年份:2005
- 资助金额:
$ 23.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Antiatherogenic Properties of tert-Butylhydroquinone
叔丁基氢醌的抗动脉粥样硬化特性
- 批准号:
6786512 - 财政年份:2004
- 资助金额:
$ 23.76万 - 项目类别:
Antiatherogenic action of estrogen through inhibition of pathological proliferation in vascular smooth muscle sells
雌激素通过抑制血管平滑肌病理性增殖发挥抗动脉粥样硬化作用
- 批准号:
14370523 - 财政年份:2002
- 资助金额:
$ 23.76万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
- 批准号:
6115236 - 财政年份:1998
- 资助金额:
$ 23.76万 - 项目类别:
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
- 批准号:
6276470 - 财政年份:1997
- 资助金额:
$ 23.76万 - 项目类别:
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
- 批准号:
6168341 - 财政年份:1996
- 资助金额:
$ 23.76万 - 项目类别:
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
- 批准号:
2769196 - 财政年份:1996
- 资助金额:
$ 23.76万 - 项目类别: